09 Jan 2007 Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
09 Jan 2007 Seattle Genetics to Present at the JPMorgan Annual Healthcare Conference
09 Jan 2007 Protherics submits DigiFab(TM) New Drug Submission in Canada
09 Jan 2007 Cytochroma Inc. and aOvaTechnologies, Inc., Sign License Agreement.
09 Jan 2007 Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
09 Jan 2007 Antibody-Company f-star Raises EUR1.5 Million in Seed Financing Round From Atlas Venture
06 Jan 2007 Helix BioPharma Corp. signs L-DOS47 manufacturing agreement with BioVectra dcl
06 Jan 2007 DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
05 Jan 2007 Elusys Announces Collaborative Research And License Agreement With Pfizer
05 Jan 2007 Medarex Announces Enrollment Complete in Ipilimumab (MDX-010) Monotherapy Pivotal Registrational Trial for Metastatic Melanoma
05 Jan 2007 Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
05 Jan 2007 Genentech Announces Positive Results from a Randomized Phase II Study of Pertuzumab in Combination with Gemcitabine for Advanced Ovarian Cancer
04 Jan 2007 MacroGenics and JDRF Form Partnership to Support Pivotal Phase II/III Clinical Trial of Anti-CD3 Monoclonal Antibody for Children and Adults With Recent-Onset Type 1 Diabetes
04 Jan 2007 Imclone Systems Commences Patient Treatment in U.S. Phase I Clinical Trial of IMC-3G3

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up